Steven Cohen's position in Beam Therapeutics is currently worth $3.34 Million. That's 0.01% of their equity portfolio (626th largest holding). The first Beam Therapeutics trade was made in Q2 2020. Since then Steven Cohen bought shares three more times and sold shares on three occasions. The investor's estimated purchase price is $4.96 Million, resulting in a loss of 33%.